Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,397 | -828 | 956 | -8,860 | -5,823 |
| Depreciation Amortization | 519 | 401 | 266 | 649 | 395 |
| Accounts receivable | 5,397 | 4,898 | 8,683 | -4,094 | 345 |
| Accounts payable and accrued liabilities | -1,365 | -709 | -1,776 | -910 | -211 |
| Other Working Capital | 4,809 | 3,541 | -308 | 867 | 3,341 |
| Other Operating Activity | -8,986 | -9,662 | -7,261 | 8,463 | 476 |
| Operating Cash Flow | $-2,023 | $-2,359 | $560 | $-3,885 | $-1,477 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | -59 | -57 | -569 | -523 |
| Investing Cash Flow | $-59 | $-59 | $-57 | $-569 | $-523 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,808 | 2,808 | N/A | N/A | 397 |
| Debt Issued | N/A | N/A | N/A | 397 | N/A |
| Debt Repayment | N/A | N/A | N/A | -782 | N/A |
| Other Financing Activity | -627 | -383 | -135 | 5,000 | 1,745 |
| Financing Cash Flow | $2,181 | $2,425 | $-135 | $4,615 | $2,142 |
| Beginning Cash Position | 741 | 741 | 741 | 580 | 580 |
| End Cash Position | 840 | 748 | 1,109 | 741 | 722 |
| Net Cash Flow | $99 | $7 | $368 | $161 | $142 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,023 | -2,359 | 560 | -3,885 | -1,477 |
| Capital Expenditure | -59 | -59 | -57 | -569 | -523 |
| Free Cash Flow | -2,082 | -2,418 | 503 | -4,454 | -2,000 |